OnKure Therapeutics, Inc. OKUR Payment Of Reverse Recapitalization Transaction Costs
Payment Of Reverse Recapitalization Transaction Costs at other companies
Other financials
Where this comes from
Reported directly by OnKure Therapeutics, Inc. in its filing.
Tagged under the XBRL concept okur:PaymentOfReverseRecapitalizationTransactionCosts.
The official record: OnKure Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about OnKure Therapeutics, Inc.'s payment of reverse recapitalization transaction costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OnKure Therapeutics, Inc.'s payment of reverse recapitalization transaction costs?
- OnKure Therapeutics, Inc. (OKUR) reported payment of reverse recapitalization transaction costs of $40K in Q1 2025.
- How has OnKure Therapeutics, Inc.'s payment of reverse recapitalization transaction costs changed year-over-year?
- OnKure Therapeutics, Inc.'s payment of reverse recapitalization transaction costs decreased by 92.2% year-over-year, from $511.25K to $40K.
- What does payment of reverse recapitalization transaction costs mean?
- Cash outflows related to professional fees, legal expenses, and administrative costs incurred to execute a reverse recapitalization or reverse merger. These costs represent non-recurring expenditures required to transition the company into a publicly traded entity.